{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:00Z","timestamp":1792801380571,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-04073-9","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:24:29Z","timestamp":1734546269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Manipulated mesenchymal stem cell therapy in the treatment of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Seyedeh Toktam","family":"Ekrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Haghmorad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiar Kamal","family":"Kheder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-4170","authenticated-orcid":false,"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"1","key":"4073_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","volume":"81","author":"N Singh","year":"2007","unstructured":"Singh N, Pillay V, Choonara YE. Advances in the treatment of Parkinson\u2019s disease. Prog Neurobiol. 2007;81(1):29\u201344.","journal-title":"Prog Neurobiol"},{"key":"4073_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113015","volume":"142","author":"N Ebadpour","year":"2024","unstructured":"Ebadpour N, Mahmoudi M, Kheder RK, Abavisani M, Baridjavadi Z, Abdollahi N, et al. From mitochondrial dysfunction to neuroinflammation in Parkinson\u2019s disease: pathogenesis and mitochondrial therapeutic approaches. Int Immunopharmacol. 2024;142: 113015.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"4073_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4109","volume":"42","author":"Z Baridjavadi","year":"2024","unstructured":"Baridjavadi Z, Mahmoudi M, Abdollahi N, Ebadpour N, Mollazadeh S, Haghmorad D, et al. The humoral immune landscape in Parkinson\u2019s disease: Unraveling antibody and B cell changes. Cell Biochem Funct. 2024;42(7): e4109.","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"4073_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4073_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-10-1","volume":"10","author":"M Politis","year":"2012","unstructured":"Politis M, Lindvall O. Clinical application of stem cell therapy in Parkinson\u2019s disease. BMC Med. 2012;10(1):1.","journal-title":"BMC Med"},{"issue":"2","key":"4073_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1574888X18666230222144116","volume":"19","author":"A Nasrolahi","year":"2024","unstructured":"Nasrolahi A, Shabani Z, Sadigh-Eteghad S, Salehi-Pourmehr H, Mahmoudi J. Stem cell therapy for the treatment of Parkinson\u2019s disease: what promise does it hold? Curr Stem Cell Res Ther. 2024;19(2):185\u201399.","journal-title":"Curr Stem Cell Res Ther"},{"key":"4073_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111306","volume":"126","author":"S Hosseini","year":"2024","unstructured":"Hosseini S, Mahmoudi M, Rezaieyazdi Z, Shapouri-Moghaddam A, Hosseinzadeh A, Arab FL, et al. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome. Int Immunopharmacol. 2024;126: 111306.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4073_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2174\/1570159X20666220327212414","volume":"21","author":"A Unnisa","year":"2023","unstructured":"Unnisa A, Dua K, Kamal MA. Mechanism of mesenchymal stem cells as a multitarget disease-modifying therapy for Parkinson\u2019s disease. Curr Neuropharmacol. 2023;21(4):988.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"4073_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s13287-023-03578-z","volume":"14","author":"A Hoseinzadeh","year":"2023","unstructured":"Hoseinzadeh A, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Tavakol Afshari J, Hosseini S, et al. A new generation of mesenchymal stromal\/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment. Stem Cell Res Ther. 2023;14(1):358.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4073_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/cbin.12171","volume":"48","author":"S Zargarani","year":"2024","unstructured":"Zargarani S, Tavaf MJ, Soltanmohammadi A, Yazdanpanah E, Baharlou R, Yousefi B, et al. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1\/Th17 and expansion of Th2\/Treg responses. Cell Biol Int. 2024;48(8):1124\u201337.","journal-title":"Cell Biol Int"},{"issue":"11","key":"4073_CR11","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/iub.2387","volume":"72","author":"F Radmanesh","year":"2020","unstructured":"Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR, et al. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life. 2020;72(11):2366\u201381.","journal-title":"IUBMB Life"},{"issue":"5","key":"4073_CR12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","volume":"18","author":"D Jovic","year":"2022","unstructured":"Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F, et al. A brief overview of global trends in msc-based cell therapy. Stem Cell Rev Rep. 2022;18(5):1525\u201345.","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"4073_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-3940(01)02384-9","volume":"316","author":"Y Li","year":"2001","unstructured":"Li Y, Chen J, Wang L, Zhang L, Lu M, Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Neurosci Lett. 2001;316(2):67\u201370.","journal-title":"Neurosci Lett"},{"key":"4073_CR14","unstructured":"Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation [Internet]. American Society for Clinical Investigation; 2004 [cited 2024 Apr 15]. Available from: https:\/\/www.jci.org\/articles\/view\/20935\/pdf"},{"issue":"1","key":"4073_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/glia.20731","volume":"57","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia. 2009;57(1):13\u201323.","journal-title":"Glia"},{"issue":"2","key":"4073_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3727\/096368909X479839","volume":"19","author":"F Blandini","year":"2010","unstructured":"Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G, Bossolasco P, et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 2010;19(2):203\u201318.","journal-title":"Cell Transplant"},{"issue":"3","key":"4073_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4252\/wjsc.v8.i3.106","volume":"8","author":"HH Ahmed","year":"2016","unstructured":"Ahmed HH, Salem AM, Atta HM, Eskandar EF, Farrag ARH, Ghazy MA, et al. Updates in the pathophysiological mechanisms of Parkinson\u2019s disease: emerging role of bone marrow mesenchymal stem cells. World J Stem Cells. 2016;8(3):106.","journal-title":"World J Stem Cells"},{"issue":"3","key":"4073_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3892\/etm.2017.4073","volume":"13","author":"M Salama","year":"2017","unstructured":"Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, et al. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson\u2019s disease. Exp Ther Med. 2017;13(3):976\u201382.","journal-title":"Exp Ther Med"},{"issue":"2","key":"4073_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jcyt.2014.09.005","volume":"17","author":"A Schwerk","year":"2015","unstructured":"Schwerk A, Altsch\u00fcler J, Roch M, Gossen M, Winter C, Berg J, et al. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning. Cytotherapy. 2015;17(2):199\u2013214.","journal-title":"Cytotherapy"},{"key":"4073_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2021.104703","volume":"123","author":"M Forouzandeh","year":"2021","unstructured":"Forouzandeh M, Bigdeli MR, Mostafavi H, Nadri S, Eskandari M. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson\u2019s disease. Exp Mol Pathol. 2021;123: 104703.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"4073_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2007.10.011","volume":"210","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Martinez TN, Ruhn KA, Wrage PC, Keefer EW, Botterman BR, et al. Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson\u2019s disease. Exp Neurol. 2008;210(1):14\u201329.","journal-title":"Exp Neurol"},{"issue":"2","key":"4073_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","volume":"155","author":"NK Venkataramana","year":"2010","unstructured":"Venkataramana NK, Kumar SKV, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease. Transl Res. 2010;155(2):62\u201370.","journal-title":"Transl Res"},{"issue":"36","key":"4073_CR23","first-page":"6833","volume":"15","author":"Y Qiu","year":"2011","unstructured":"Qiu Y, Wang Z, Lu H. Umbilical cord mesenchymal stem cell transplantation for treatment of Parkinson\u2019s disease in 8 cases. Chin J Tissue Eng Res. 2011;15(36):6833.","journal-title":"Chin J Tissue Eng Res"},{"issue":"6","key":"4073_CR24","first-page":"932","volume":"18","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhao X. Therapeutic applications of umbilical cord mesenchymal stem cells in Parkinson\u2019s disease. Chin J Tissue Eng Res. 2014;18(6):932.","journal-title":"Chin J Tissue Eng Res"},{"issue":"1","key":"4073_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12967-016-0880-2","volume":"14","author":"M Canesi","year":"2016","unstructured":"Canesi M, Giordano R, Lazzari L, Isalberti M, Isaias IU, Benti R, et al. Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy. J Transl Med. 2016;14(1):127.","journal-title":"J Transl Med"},{"issue":"2","key":"4073_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1166\/jbt.2016.1425","volume":"6","author":"WT Wang","year":"2016","unstructured":"Wang WT, Gu P, Qiu FC, Zhang LN, Zhang ZX, Xie BC, et al. Intravenous transplantation of allograft hUC-MSC was more effective than subarachnoid transplantation of bm-mscs in patients with Parkinson\u2019s syndrome and secondary Parkinson\u2019s syndrome. J Biomater Tissue Eng. 2016;6(2):158\u201364.","journal-title":"J Biomater Tissue Eng"},{"issue":"11","key":"4073_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.25259\/SNI_233_2020","volume":"11","author":"A Boika","year":"2020","unstructured":"Boika A, Aleinikava N, Chyzhyk V, Zafranskaya M, Nizheharodava D, Ponomarev V. Mesenchymal stem cells in Parkinson\u2019s disease: motor and nonmotor symptoms in the early posttransplant period. Surg Neurol Int. 2020;11(11):380.","journal-title":"Surg Neurol Int"},{"issue":"8","key":"4073_CR28","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.28582","volume":"36","author":"M Schiess","year":"2021","unstructured":"Schiess M, Suescun J, Doursout MF, Adams C, Green C, Saltarrelli JG, et al. Allogeneic bone marrow-derived mesenchymal stem cell safety in idiopathic Parkinson\u2019s disease. Mov Disord. 2021;36(8):1825\u201334.","journal-title":"Mov Disord"},{"issue":"1","key":"4073_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ane.13547","volume":"145","author":"K Shigematsu","year":"2022","unstructured":"Shigematsu K, Komori N, Tahara K, Yamagishi H. Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson\u2019s disease. Acta Neurol Scand. 2022;145(1):119\u201322.","journal-title":"Acta Neurol Scand"},{"key":"4073_CR30","doi-asserted-by":"publisher","unstructured":"Raghavan P. Metadichol\u00ae induced expression of neuronal transcription factors with Human fibroblast Dermal cell [Internet]. 2022 [cited 2024 Oct 23]. Available from: https:\/\/doi.org\/10.21203\/rs.3.rs-1983481\/v1","DOI":"10.21203\/rs.3.rs-1983481\/v1"},{"issue":"1","key":"4073_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-022-00544-w","volume":"17","author":"M Al-Nusaif","year":"2022","unstructured":"Al-Nusaif M, Yang Y, Li S, Cheng C, Le W. The role of NURR1 in metabolic abnormalities of Parkinson\u2019s disease. Mol Neurodegener. 2022;17(1):46.","journal-title":"Mol Neurodegener"},{"key":"4073_CR32","doi-asserted-by":"crossref","unstructured":"The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration [Internet]. [cited 2024 Oct 23]. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8614","DOI":"10.3390\/ijms24108614"},{"issue":"5","key":"4073_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.15252\/emmm.201404610","volume":"7","author":"S Oh","year":"2015","unstructured":"Oh S, Chang M, Song J, Rhee Y, Joe E, Lee H, et al. Combined Nurr1 and Foxa2 roles in the therapy of Parkinson\u2019s disease. EMBO Mol Med. 2015;7(5):510\u201325.","journal-title":"EMBO Mol Med"},{"key":"4073_CR34","doi-asserted-by":"publisher","unstructured":"Wolfrum P, Fietz A, Schnichels S, Hurst J. The function of p53 and its role in Alzheimer\u2019s and Parkinson\u2019s disease compared to age-related macular degeneration. Front Neurosci [Internet]. 2022 Dec 21 [cited 2024 Oct 24];16. Available from: https:\/\/doi.org\/10.3389\/fnins.2022.1029473\/full","DOI":"10.3389\/fnins.2022.1029473\/full"},{"issue":"11","key":"4073_CR35","doi-asserted-by":"publisher","first-page":"dev199508","DOI":"10.1242\/dev.199508","volume":"149","author":"JD Price","year":"2022","unstructured":"Price JD, Lindtner S, Ypsilanti A, Binyameen F, Johnson JR, Newton BW, et al. DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. Development. 2022;149(11):dev199508.","journal-title":"Development"},{"issue":"13","key":"4073_CR36","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1128\/MCB.25.13.5699-5711.2005","volume":"25","author":"F Laub","year":"2005","unstructured":"Laub F, Lei L, Sumiyoshi H, Kajimura D, Dragomir C, Smaldone S, et al. Transcription factor KLF7 is important for neuronal morphogenesis in selected regions of the nervous system. Mol Cell Biol. 2005;25(13):5699\u2013711.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4073_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13287-022-02822-2","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Jiang Y, Hou Q, Zhao Y, Zhong L, Fu X. Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects. Stem Cell Res Ther. 2022;13(1):146.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4073_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.15283\/ijsc19031","volume":"13","author":"S Omid Sadatpoor","year":"2020","unstructured":"Omid Sadatpoor S, Salehi Z, Rahban D, Salimi A. Manipulated mesenchymal stem cells applications in neurodegenerative diseases. Int J Stem Cells. 2020;13(1):24.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"4073_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"NDC Noronha","year":"2019","unstructured":"Noronha NDC, Mizukami A, Cali\u00e1ri-Oliveira C, Cominal JG, Rocha JLM, Covas DT, et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10(1):131.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4073_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4252\/wjsc.v15.i5.400","volume":"15","author":"V Miceli","year":"2023","unstructured":"Miceli V, Zito G, Bulati M, Gallo A, Bus\u00e0 R, Iannolo G, et al. Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal\/stem cells: potential implications for their clinical use. World J Stem Cells. 2023;15(5):400\u201320.","journal-title":"World J Stem Cells"},{"issue":"6","key":"4073_CR41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3892\/etm.2021.10791","volume":"22","author":"R Kurogoushi","year":"2021","unstructured":"Kurogoushi R, Hasegawa T, Akazawa Y, Iwata K, Sugimoto A, Yamaguchi-ueda K, et al. Fibroblast growth factor 2 suppresses the expression of C-C motif chemokine 11 through the c-Jun N-terminal kinase pathway in human dental pulp-derived mesenchymal stem cells. Exp Ther Med. 2021;22(6):1356.","journal-title":"Exp Ther Med"},{"issue":"11\u201312","key":"4073_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1089\/ten.tea.2018.0177","volume":"25","author":"K Endo","year":"2019","unstructured":"Endo K, Fujita N, Nakagawa T, Nishimura R. Effect of fibroblast growth factor-2 and serum on canine mesenchymal stem cell chondrogenesis. Tissue Eng Part A. 2019;25(11\u201312):901\u201310.","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"4073_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/SHK.0b013e3181b7d137","volume":"33","author":"JL Herrmann","year":"2010","unstructured":"Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock Augusta Ga. 2010;33(1):24\u201330.","journal-title":"Shock Augusta Ga"},{"issue":"9","key":"4073_CR44","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2007.11.040","volume":"51","author":"JY Hahn","year":"2008","unstructured":"Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH, et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008;51(9):933\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4073_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2008.09.003","volume":"376","author":"J Pons","year":"2008","unstructured":"Pons J, Huang Y, Arakawa-Hoyt J, Washko D, Takagawa J, Ye J, et al. VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun. 2008;376(2):419\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"4073_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13238-011-1097-z","volume":"2","author":"X Liu","year":"2011","unstructured":"Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, et al. SDF-1\/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell. 2011;2(10):845\u201354.","journal-title":"Protein Cell"},{"issue":"1","key":"4073_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40635-020-0295-5","volume":"8","author":"S Horie","year":"2020","unstructured":"Horie S, Gaynard S, Murphy M, Barry F, Scully M, O\u2019Toole D, et al. Cytokine pre-activation of cryopreserved xenogeneic-free human mesenchymal stromal cells enhances resolution and repair following ventilator-induced lung injury potentially via a KGF-dependent mechanism. Intensive Care Med Exp. 2020;8(1):8.","journal-title":"Intensive Care Med Exp"},{"key":"4073_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/638153","volume":"2015","author":"J Liu","year":"2015","unstructured":"Liu J, Zhu P, Song P, Xiong W, Chen H, Peng W, et al. Pretreatment of adipose derived stem cells with curcumin facilitates myocardial recovery via antiapoptosis and angiogenesis. Stem Cells Int. 2015;2015: 638153.","journal-title":"Stem Cells Int"},{"issue":"6","key":"4073_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/cells9061467","volume":"9","author":"DW Kim","year":"2020","unstructured":"Kim DW, Choi CH, Park JP, Lee SJ. Nanospheres loaded with curcumin improve the bioactivity of umbilical cord blood-mesenchymal stem cells via c-Src activation during the skin wound healing process. Cells. 2020;9(6):1467.","journal-title":"Cells"},{"issue":"7","key":"4073_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17874","volume":"9","author":"Y Huang","year":"2023","unstructured":"Huang Y, Liu J, He J, Tan F, Lu M, Yuan F, et al. Curcumin preconditioning enhances the neuroprotective effects of olfactory mucosa-derived mesenchymal stem cells on experimental intracerebral hemorrhage. Heliyon. 2023;9(7): e17874.","journal-title":"Heliyon"},{"issue":"2","key":"4073_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.joca.2016.09.014","volume":"25","author":"FU Bhatti","year":"2017","unstructured":"Bhatti FU, Mehmood A, Latief N, Zahra S, Cho H, Khan SN, et al. Vitamin E protects rat mesenchymal stem cells against hydrogen peroxide-induced oxidative stress in vitro and improves their therapeutic potential in surgically-induced rat model of osteoarthritis. Osteoarthritis Cartilage. 2017;25(2):321\u201331.","journal-title":"Osteoarthritis Cartilage"},{"key":"4073_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.reth.2022.07.011","volume":"21","author":"F Irfan","year":"2022","unstructured":"Irfan F, Jameel F, Khan I, Aslam R, Faizi S, Salim A. Role of quercetin and rutin in enhancing the therapeutic potential of mesenchymal stem cells for cold induced burn wound. Regen Ther. 2022;21:225\u201338.","journal-title":"Regen Ther"},{"key":"4073_CR53","unstructured":"Ex vivo pretreatment with melatonin improves survival, proangiogenic\/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney - PubMed [Internet]. [cited 2024 Jun 25]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18467662\/"},{"issue":"1","key":"4073_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cbin.11211","volume":"44","author":"N Alijani","year":"2020","unstructured":"Alijani N, Johari B, Moradi M, Kadivar M. A review on transcriptional regulation responses to hypoxia in mesenchymal stem cells. Cell Biol Int. 2020;44(1):14\u201326.","journal-title":"Cell Biol Int"},{"issue":"6","key":"4073_CR55","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/ijms18061320","volume":"18","author":"JH Lee","year":"2017","unstructured":"Lee JH, Yoon YM, Lee SH. Hypoxic preconditioning promotes the bioactivities of mesenchymal stem cells via the HIF-1\u03b1-GRP78-Akt Axis. Int J Mol Sci. 2017;18(6):1320.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4073_CR56","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/ten.teb.2021.0145","volume":"28","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lee EH, Yang Z. Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application. Tissue Eng Part B Rev. 2022;28(5):966\u201377.","journal-title":"Tissue Eng Part B Rev"},{"key":"4073_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/632972","volume":"2013","author":"N Haque","year":"2013","unstructured":"Haque N, Rahman MT, Abu Kasim NH, Alabsi AM. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. Sci World J. 2013;2013:1\u201312.","journal-title":"Sci World J"},{"issue":"1","key":"4073_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/stmcls\/sxac073","volume":"41","author":"N Farooqui","year":"2023","unstructured":"Farooqui N, Mohan A, Isik B, Goksu BB, Thaler R, Zhu XY, et al. Effect of hypoxia preconditioning on the regenerative capacity of adipose tissue derived mesenchymal stem cells in a model of renal artery stenosis. Stem Cells. 2023;41(1):50\u201363.","journal-title":"Stem Cells"},{"issue":"1","key":"4073_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13287-015-0018-0","volume":"6","author":"B Huang","year":"2015","unstructured":"Huang B, Li G, Jiang XH. Fate determination in mesenchymal stem cells: a perspective from histone-modifying enzymes. Stem Cell Res Ther. 2015;6(1):35.","journal-title":"Stem Cell Res Ther"},{"key":"4073_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fimmu.2013.00203","volume":"4","author":"M Roemeling-van Rhijn","year":"2013","unstructured":"Roemeling-van Rhijn M, Mensah FK, Korevaar SS, Leijs MJ, van Osch GJ, et al. Effects of hypoxia on the immunomodulatory properties of adipose tissue-derived mesenchymal stem cells. Front Immunol. 2013;4:203.","journal-title":"Front Immunol"},{"issue":"3","key":"4073_CR61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2184.2012.00817.x","volume":"45","author":"MG Valorani","year":"2012","unstructured":"Valorani MG, Montelatici E, Germani A, Biddle A, D\u2019Alessandro D, Strollo R, et al. Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials. Cell Prolif. 2012;45(3):225\u201338.","journal-title":"Cell Prolif"},{"issue":"8","key":"4073_CR62","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","volume":"26","author":"I Rosov\u00e1","year":"2008","unstructured":"Rosov\u00e1 I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008;26(8):2173\u201382.","journal-title":"Stem Cells"},{"issue":"4","key":"4073_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/scrt234","volume":"4","author":"J Yu","year":"2013","unstructured":"Yu J, Yin S, Zhang W, Gao F, Liu Y, Chen Z, et al. Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model. Stem Cell Res Ther. 2013;4(4):83.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4073_CR64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","volume":"135","author":"X Hu","year":"2008","unstructured":"Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008;135(4):799\u2013808.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"4073_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/CH-141883","volume":"58","author":"W Wang","year":"2014","unstructured":"Wang W, Xu X, Li Z, Lendlein A, Ma N. Genetic engineering of mesenchymal stem cells by non-viral gene delivery. Clin Hemorheol Microcirc. 2014;58(1):19\u201348.","journal-title":"Clin Hemorheol Microcirc"},{"key":"4073_CR66","doi-asserted-by":"publisher","unstructured":"Nie WB, Zhang D, Wang LS. Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration. Drug Des Devel Ther [Internet]. 2020 Mar 26 [cited 2024 Jun 27]; Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.2147\/DDDT.S243944","DOI":"10.2147\/DDDT.S243944"},{"issue":"3","key":"4073_CR67","first-page":"383","volume":"278","author":"CT Huerta","year":"2023","unstructured":"Huerta CT, Ortiz YY, Li Y, Ribieras AJ, Voza F, Le N, et al. Novel gene-modified mesenchymal stem cell therapy reverses impaired wound healing in ischemic limbs. Ann Surg. 2023;278(3):383.","journal-title":"Ann Surg"},{"issue":"3","key":"4073_CR68","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3109\/21691401.2016.1160918","volume":"45","author":"AC Vural","year":"2017","unstructured":"Vural AC, Odabas S, Korkusuz P, Yar Sa\u011flam AS, Bilgi\u00e7 E, \u00c7avu\u015fo\u011flu T, et al. Cranial bone regeneration via BMP-2 encoding mesenchymal stem cells. Artif Cells Nanomedicine Biotechnol. 2017;45(3):544\u201350.","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"issue":"1","key":"4073_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mvr.2008.02.005","volume":"76","author":"XH Liu","year":"2008","unstructured":"Liu XH, Bai CG, Xu ZY, Huang SD, Yuan Y, Gong DJ, et al. Therapeutic potential of angiogenin modified mesenchymal stem cells: Angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc Res. 2008;76(1):23\u201330.","journal-title":"Microvasc Res"},{"key":"4073_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.expneurol.2013.06.028","volume":"248","author":"G Kumagai","year":"2013","unstructured":"Kumagai G, Tsoulfas P, Toh S, McNiece I, Bramlett HM, Dietrich WD. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol. 2013;248:369\u201380.","journal-title":"Exp Neurol"},{"issue":"1","key":"4073_CR71","first-page":"48","volume":"11","author":"Y Zhuo","year":"2024","unstructured":"Zhuo Y, Li WS, Lu W, Li X, Ge LT, Huang Y, et al. TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson\u2019s disease models and patients. Mil Med Res. 2024;11(1):48.","journal-title":"Mil Med Res"},{"issue":"1","key":"4073_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s13287-022-03139-w","volume":"13","author":"JY Shin","year":"2022","unstructured":"Shin JY, Kim DY, Lee J, Shin YJ, Kim YS, Lee PH. Priming mesenchymal stem cells with \u03b1-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models. Stem Cell Res Ther. 2022;13(1):483.","journal-title":"Stem Cell Res Ther"},{"key":"4073_CR73","doi-asserted-by":"publisher","first-page":"204173142110048","DOI":"10.1177\/20417314211004816","volume":"12","author":"HN Kim","year":"2021","unstructured":"Kim HN, Shin JY, Kim DY, Lee JE, Lee PH. Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models. J Tissue Eng. 2021;12:20417314211004816.","journal-title":"J Tissue Eng"},{"issue":"9","key":"4073_CR74","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/cells9092058","volume":"9","author":"M Singh","year":"2020","unstructured":"Singh M, Vaishnav PK, Dinda AK, Mohanty S. Evaluation of priming efficiency of forskolin in tissue-specific human mesenchymal stem cells into dopaminergic neurons: an in vitro comparative study. Cells. 2020;9(9):2058.","journal-title":"Cells"},{"key":"4073_CR75","doi-asserted-by":"crossref","unstructured":"Wang YL, Liu XS, Wang SS, Xue P, Zeng ZL, Yang XP, et al. Curcumin-activated mesenchymal stem cells derived from human umbilical cord and their effects on MPTP-mouse model of Parkinson\u2019s disease: a new biological therapy for Parkinson\u2019s disease. Stem Cells Int [Internet]. 2020 [cited 2024 May 1];2020. Available from: https:\/\/www.hindawi.com\/journals\/sci\/2020\/4636397\/","DOI":"10.1155\/2020\/4636397"},{"issue":"6","key":"4073_CR76","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1039\/C7NR06976F","volume":"10","author":"TH Chung","year":"2018","unstructured":"Chung TH, Hsu SC, Wu SH, Hsiao JK, Lin CP, Yao M, et al. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson\u2019s disease. Nanoscale. 2018;10(6):2998\u20133007.","journal-title":"Nanoscale"},{"key":"4073_CR77","doi-asserted-by":"crossref","unstructured":"Jinfeng L, Yunliang W, Xinshan L, Yutong W, Shanshan W, Peng X, et al. Therapeutic effects of CUR-activated human umbilical cord mesenchymal stem cells on 1-methyl-4-phenylpyridine-induced Parkinson\u2019s disease cell model. BioMed Res Int [Internet]. 2016 [cited 2024 May 1];2016. Available from: https:\/\/www.hindawi.com\/journals\/bmri\/2016\/9140541\/abs\/","DOI":"10.1155\/2016\/9140541"},{"issue":"6","key":"4073_CR78","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s11064-015-1816-6","volume":"41","author":"C Zhao","year":"2016","unstructured":"Zhao C, Li H, Zhao XJ, Liu ZX, Zhou P, Liu Y, et al. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson\u2019s disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons. Neurochem Res. 2016;41(6):1238\u201349.","journal-title":"Neurochem Res"},{"issue":"2","key":"4073_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cbin.10029","volume":"37","author":"P Shetty","year":"2013","unstructured":"Shetty P, Thakur AM, Viswanathan C. Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson\u2019s disease rodent model. Cell Biol Int. 2013;37(2):167\u201380.","journal-title":"Cell Biol Int"},{"issue":"5","key":"4073_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019025","volume":"6","author":"ML Khoo","year":"2011","unstructured":"Khoo ML, Tao H, Meedeniya AC, Mackay-Sim A, Ma DD. Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS ONE. 2011;6(5): e19025.","journal-title":"PLoS ONE"},{"issue":"11","key":"4073_CR81","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.bbmt.2010.06.006","volume":"16","author":"R Somoza","year":"2010","unstructured":"Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson\u2019s disease. Biol Blood Marrow Transplant. 2010;16(11):1530\u201340.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"4073_CR82","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s11064-010-0211-6","volume":"35","author":"M Li","year":"2010","unstructured":"Li M, Zhang SZ, Guo YW, Cai Y, et al. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson\u2019s disease. Neurochem Res. 2010;35(10):1522\u20139.","journal-title":"Neurochem Res"},{"issue":"8","key":"4073_CR83","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.cellbi.2009.05.002","volume":"33","author":"P Shetty","year":"2009","unstructured":"Shetty P, Ravindran G, Sarang S, Thakur AM, Rao HS, Viswanathan C. Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson\u2019s disease. Cell Biol Int. 2009;33(8):830\u20138.","journal-title":"Cell Biol Int"},{"issue":"8","key":"4073_CR84","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/scd.2008.0411","volume":"18","author":"O Sadan","year":"2009","unstructured":"Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, et al. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA Rat model of Parkinson disease. Stem Cells Dev. 2009;18(8):1179\u201390.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"4073_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/scd.2007.0172","volume":"17","author":"R Barzilay","year":"2008","unstructured":"Barzilay R, Kan I, Ben-Zur T, Bulvik S, Melamed E, Offen D. Induction of Human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev. 2008;17(3):547\u201354.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4073_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054296","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Yang J, Li H, Wang X, Zhu L, Fan M, et al. Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson\u2019s disease. PLoS ONE. 2013;8(1): e54296.","journal-title":"PLoS ONE"},{"key":"4073_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2022.103784","volume":"123","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Wang J, Sun G, Feng M. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson\u2019s disease rats through neuroprotection and anti-neuroinflammation. Mol Cell Neurosci. 2022;123: 103784.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"4073_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41531-022-00440-6","volume":"8","author":"J Li","year":"2022","unstructured":"Li J, Li N, Wei J, Feng C, Chen Y, Chen T, et al. Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson\u2019s disease in animal models. Npj Park Dis. 2022;8(1):175.","journal-title":"Npj Park Dis"},{"issue":"1","key":"4073_CR89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15283\/ijsc18110","volume":"12","author":"J Lee","year":"2019","unstructured":"Lee J, Bayarsaikhan D, Arivazhagan R, Park H, Lim B, Gwak P, et al. CRISPR\/Cas9 edited sRAGE-MSCs protect neuronal death in Parkinson\u2019s disease model. Int J Stem Cells. 2019;12(1):114.","journal-title":"Int J Stem Cells"},{"issue":"6","key":"4073_CR90","first-page":"1583","volume":"10","author":"X Wang","year":"2018","unstructured":"Wang X, Zhuang W, Fu W, Wang X, Lv E, Li F, et al. The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson\u2019s disease. Am J Transl Res. 2018;10(6):1583.","journal-title":"Am J Transl Res"},{"key":"4073_CR91","doi-asserted-by":"crossref","unstructured":"Jinfeng L, Yunliang W, Xinshan L, Shanshan W, Chunyang X, Peng X, et al. The effect of MSCs derived from the human umbilical cord transduced by fibroblast growth factor-20 on Parkinson\u2019s disease. Stem Cells Int [Internet]. 2016 [cited 2024 May 1];2016. Available from: https:\/\/www.hindawi.com\/journals\/sci\/2016\/5016768\/abs\/","DOI":"10.1155\/2016\/5016768"},{"issue":"2","key":"4073_CR92","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10072-014-1929-8","volume":"36","author":"M Jiaming","year":"2015","unstructured":"Jiaming M, Niu C. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson\u2019s disease. Neurol Sci. 2015;36(2):281\u20137.","journal-title":"Neurol Sci"},{"issue":"8","key":"4073_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105118","volume":"9","author":"X Yin","year":"2014","unstructured":"Yin X, Xu H, Jiang Y, Deng W, Wu Z, Xiang H, et al. The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson\u2019s disease rat model. PLoS ONE. 2014;9(8): e105118.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"4073_CR94","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-013-1701-z","volume":"381","author":"JF Li","year":"2013","unstructured":"Li JF, Yin HL, Shuboy A, Duan HF, Lou JY, Li J, et al. Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor. Mol Cell Biochem. 2013;381(1\u20132):183\u201390.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"4073_CR95","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/gt.2010.152","volume":"18","author":"N Xiong","year":"2011","unstructured":"Xiong N, Zhang Z, Huang J, Chen C, Jia M, Xiong J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson\u2019s disease. Gene Ther. 2011;18(4):394\u2013402.","journal-title":"Gene Ther"},{"issue":"1","key":"4073_CR96","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10072-010-0385-3","volume":"32","author":"D Shi","year":"2011","unstructured":"Shi D, Chen G, Lv L, Li L, Wei D, Gu P, et al. The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson\u2019s disease rat model. Neurol Sci. 2011;32(1):41\u201351.","journal-title":"Neurol Sci"},{"issue":"12","key":"4073_CR97","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/jnr.22435","volume":"88","author":"A Glavaski-Joksimovic","year":"2010","unstructured":"Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC. Glial cell line-derived neurotrophic factor\u2013secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson\u2019s disease. J Neurosci Res. 2010;88(12):2669\u201381.","journal-title":"J Neurosci Res"},{"issue":"3","key":"4073_CR98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11064-009-0086-6","volume":"35","author":"J Wu","year":"2010","unstructured":"Wu J, Yu W, Chen Y, Su Y, Ding Z, Ren H, et al. Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced parkinsonian rat model. Neurochem Res. 2010;35(3):495\u2013502.","journal-title":"Neurochem Res"},{"key":"4073_CR99","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brainres.2006.12.061","volume":"1142","author":"M Ye","year":"2007","unstructured":"Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, et al. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson\u2019s disease. Brain Res. 2007;1142:206\u201316.","journal-title":"Brain Res"},{"issue":"1","key":"4073_CR100","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresprot.2005.03.002","volume":"15","author":"L Lu","year":"2005","unstructured":"Lu L, Zhao C, Liu Y, Sun X, Duan C, Ji M, et al. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson\u2019s disease. Brain Res Protoc. 2005;15(1):46\u201351.","journal-title":"Brain Res Protoc"},{"issue":"4","key":"4073_CR101","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s12015-011-9256-4","volume":"7","author":"MCL Pereira","year":"2011","unstructured":"Pereira MCL, Secco M, Suzuki DE, Janjoppi L, Rodini CO, Torres LB, et al. Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson\u2019s disease. Stem Cell Rev Rep. 2011;7(4):1006\u201317.","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"4073_CR102","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.etap.2013.05.005","volume":"36","author":"N Xiong","year":"2013","unstructured":"Xiong N, Yang H, Liu L, Xiong J, Zhang Z, Zhang X, et al. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson\u2019s disease. Environ Toxicol Pharmacol. 2013;36(2):411\u201322.","journal-title":"Environ Toxicol Pharmacol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04073-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-04073-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04073-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T19:04:43Z","timestamp":1734548683000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-04073-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4073"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-04073-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors listed on the manuscript have agreed for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"476"}}